Regeneron Pharmaceuticals, Inc. (REGN)

2.50 0.47
Prev Close 535.48
Open 534.10
Day Low/High 534.10 / 546.72
52 Wk Low/High 328.12 / 664.64
Volume 615.51K
Exchange NASDAQ
Shares Outstanding 106.71B
Market Cap 57.86B
P/E Ratio 19.88
Div & Yield N.A. (N.A)

The Biotechs Are Back

Watch this leadership group that's been lagging.

Violent Moves in a 'Scarface' Market

The 'dead bodies' are adding up.

8 Signs the Market Is Remarkably Healthy

These are surefire indications of a bountiful tape.

A Tasty Reversal With 6 Key Ingredients

But tomorrow we hear from the banks.

Braving Biotech

Do you need to pick one name? Biotech has carried with it a lasting resiliency like few other sectors. Perhaps it is driven by optimism and hope. Perhaps it is driven by the fear of suffering or watching someone suffer from the very illnesses these ...

Regeneron upgraded at Morgan Stanley

Go With What's Worked, Part 1

Throughout this historic run, four groups have consistently led the market.

Absolutely Nothing Happened

There had been no catalysts.

Cramer: Oil-and-Gas vs. Everything Else

Reams of stocks make sense on a pullback. And what looks bad? Anything even remotely connected to oil and gas.

There's a Lot Going on Under the Hood

An immense market rotation is happening.

'Top Fishing' Is the Name of the Game

Stocks, like sports, are unfair sometimes. This is one of those times.

It Doesn't Stop

The end-of-the-year phenomenon is working.

You Have to Love Biotech

In this era of turmoil, investors can take comfort in this sector.

Here's Your Thesis to Buy

This market provides a slew of reasons to buy right now.

The Hazards of Skepticism

In this market, negativity is rarely being rewarded.

Their Weakness Is Our Strength

The U.S. markets and economy are unique.

Growth Seekers Return

Investors are seeing growth today in three areas.

How Bad Was (Fill in the Blank)?

Let's play a game.

Don't Expect Any Apologies

Still, it's a good time to review what's happening, so we never forget.

How to Game This Clueless Market

As long as you use common sense, you will be able to profit.

Leadership Is Back

Welcome back to the airlines and the biotechs.

Resistance Is Futile

Resistance Is Futile

Here are three stock that have returned to former breakout levels.

Take Solace in Biotech

This group reminds us of our nation's innovative spirit and fabulous science.

What Has Kept People Out of Stocks

Sadly, these five themes have driven folks away from the market's remarkable five-year run.

Cramer: What's Working, What's Not

Yep, the bets for the rest of 2014 are being placed.

Today's Hero Stocks

Some plays that really shine, even in low volume.

Thank Self-Help, Not the Fed

Thank Self-Help, Not the Fed

The Burger King deal exemplifies companies helping themselves and the index.

Signs of Leadership Returning

Signs of Leadership Returning

Biotech stocks are thriving in a slower-growth, low-inflation world.

Finding Winning Charts Amid the Gloom

Finding Winning Charts Amid the Gloom

These quality names look appealing on the basis of 30-week moving average.

Two Giants Blindsided by Major Trends

Two Giants Blindsided by Major Trends

McDonald's and GlaxoSmithKline are fighting against major turns of the tide.